Syeda Mariam Hasnain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Syeda Mariam Hasnain has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Amy Zang
Ontario Institute for Cancer Research
1 shared publicationAnna Dodd
Princess Margaret Cancer Centre. University Health Network, Toronto, Ontario, Canada, Wallace McCain Centre for Pancreatic Cancer, Princess Margaret Cancer Centre, University Health Network. Toronto, Ontario, Canada.
1 shared publication- Barbara Grunwald
Department of Urology, West German Cancer Center, University Hospital Essen, Essen, Germany
1 shared publication Daniela Bevacqua
Princess Margaret Cancer Centre. University Health Network, Toronto, Ontario, Canada, Wallace McCain Centre for Pancreatic Cancer, Princess Margaret Cancer Centre, University Health Network. Toronto, Ontario, Canada.
1 shared publicationErica Tsang
Princess Margaret Cancer Centre. University Health Network, Toronto, Ontario, Canada., PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research. Toronto, Ontario, Canada., Wallace McCain Centre for Pancreatic Cancer, Princess Marg
1 shared publication- Eugenia Flores-Figueroa
Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
1 shared publication
Latest Publications
- Open Access
Transcriptomic, Genomic, and Clinical Characterization of Morphological Classes in Localized and Metastatic Pancreatic Cancer
Background: Histomorphology is a strong prognostic biomarker correlated with basal-like and classical programs in surgically resected pancreatic ductal adenocarcinoma (PDAC). However, the spectrum of morphology and its biological associations remain poorly defined in advanced disease. Objectives: We explored the transcriptomic and genomic underpinnings and clinical relevance of morphological classes across localized and metastatic PDAC. Design: We unified morphological classifications into four classes: glandular, cribriform, solid, and squamous. We integrated transcriptome and whole–genome sequencing following laser–capture microdissection with morphological classifications in 348 PDAC patients, where half of the cohort included locally advance and metastatic stages to uncover molecular associations. Results: Non–glandular morphologies comprised three distinct classes that were enriched in metastatic disease. Transcriptomic profiling exhibited that glandular tumours predominantly expressed classical epithelial programs, although a subset displayed partial or full epithelial–mesenchymal transition signatures. In contrast, non–glandular morphologies showed basal–like transcriptional programs with subtype–specific pathways, including ciliogenesis in cribriform tumours, extracellular matrix remodelling and immune evasion in solid tumours, and keratinisation programs in squamous tumours. The solid class was significantly enriched in liver metastatic lesions and was associated with increased intra– tumoural morphological heterogeneity, whole-genome doubling, KRAS major allelic imbalance, and elevated KRAS–ERK signalling. Conclusion: Non–glandular morphologies identify biologically distinct PDAC tumor states that are enriched in liver metastases and associated with subtype–specific transcriptional programs and KRAS–driven genomic alterations.
Open AccessTranscriptomic, Genomic, and Clinical Characterization of Morphological Classes in Localized and Metastatic Pancreatic Cancer
Background: Histomorphology is a strong prognostic biomarker correlated with basal-like and classical programs in surgically resected pancreatic ductal adenocarcinoma (PDAC). However, the spectrum of morphology and its biological associations remain poorly defined in advanced disease. Objectives: We explored the transcriptomic and genomic underpinnings and clinical relevance of morphological classes across localized and metastatic PDAC. Design: We unified morphological classifications into four classes: glandular, cribriform, solid, and squamous. We integrated transcriptome and whole–genome sequencing following laser–capture microdissection with morphological classifications in 348 PDAC patients, where half of the cohort included locally advance and metastatic stages to uncover molecular associations. Results: Non–glandular morphologies comprised three distinct classes that were enriched in metastatic disease. Transcriptomic profiling exhibited that glandular tumours predominantly expressed classical epithelial programs, although a subset displayed partial or full epithelial–mesenchymal transition signatures. In contrast, non–glandular morphologies showed basal–like transcriptional programs with subtype–specific pathways, including ciliogenesis in cribriform tumours, extracellular matrix remodelling and immune evasion in solid tumours, and keratinisation programs in squamous tumours. The solid class was significantly enriched in liver metastatic lesions and was associated with increased intra– tumoural morphological heterogeneity, whole-genome doubling, KRAS major allelic imbalance, and elevated KRAS–ERK signalling. Conclusion: Non–glandular morphologies identify biologically distinct PDAC tumor states that are enriched in liver metastases and associated with subtype–specific transcriptional programs and KRAS–driven genomic alterations.